Unleashing Innovation: The Case for Permissionless R&D in Pharma

A recent article in Communications of the ACM explores opportunities for “Permissionless innovation” in pharmaceuticals. “Permissionless innovation” refers to the freedom to explore new technologies or businesses without needing prior…

Source


Comments are closed.

Biotechblog